Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Catheter Precision (VTAK) Raw Materials (2017 - 2025)

Catheter Precision (VTAK) has disclosed Raw Materials for 9 consecutive years, with $37000.0 as the latest value for Q4 2025.

  • Quarterly Raw Materials rose 105.56% to $37000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $37000.0 through Dec 2025, up 105.56% year-over-year, with the annual reading at $37000.0 for FY2025, 105.56% up from the prior year.
  • Raw Materials for Q4 2025 was $37000.0 at Catheter Precision, up from $23000.0 in the prior quarter.
  • The five-year high for Raw Materials was $1.9 million in Q2 2021, with the low at $18000.0 in Q4 2024.
  • Average Raw Materials over 5 years is $605363.6, with a median of $37000.0 recorded in 2025.
  • The sharpest move saw Raw Materials plummeted 60.87% in 2021, then skyrocketed 105.56% in 2025.
  • Over 5 years, Raw Materials stood at $911000.0 in 2021, then increased by 5.27% to $959000.0 in 2022, then plummeted by 97.18% to $27000.0 in 2023, then plummeted by 33.33% to $18000.0 in 2024, then surged by 105.56% to $37000.0 in 2025.
  • According to Business Quant data, Raw Materials over the past three periods came in at $37000.0, $23000.0, and $24000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.